Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Accumulated Expenses (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Accumulated Expenses readings, the most recent being $21.0 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 67.23% to $21.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.0 million, a 67.23% decrease, with the full-year FY2025 number at $21.0 million, down 67.23% from a year prior.
  • Accumulated Expenses hit $21.0 million in Q4 2025 for Tandem Diabetes Care, up from $12.5 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $64.1 million in Q4 2024 to a low of $6.3 million in Q3 2021.
  • Median Accumulated Expenses over the past 5 years was $26.9 million (2021), compared with a mean of $28.2 million.
  • The widest YoY moves for Accumulated Expenses: up 977.9% in 2021, down 79.26% in 2021.
  • Tandem Diabetes Care's Accumulated Expenses stood at $51.6 million in 2021, then decreased by 24.97% to $38.7 million in 2022, then crashed by 67.1% to $12.7 million in 2023, then skyrocketed by 403.91% to $64.1 million in 2024, then tumbled by 67.23% to $21.0 million in 2025.
  • The last three reported values for Accumulated Expenses were $21.0 million (Q4 2025), $12.5 million (Q3 2025), and $51.7 million (Q2 2025) per Business Quant data.